Compare CACC & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CACC | SHC |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.4B |
| IPO Year | 1996 | 2020 |
| Metric | CACC | SHC |
|---|---|---|
| Price | $521.24 | $15.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $505.00 | $20.33 |
| AVG Volume (30 Days) | 117.0K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.00 | 68.75 |
| EPS | ★ 36.38 | 0.27 |
| Revenue | ★ $2,317,200,000.00 | $1,163,617,000.00 |
| Revenue This Year | $91.73 | $7.51 |
| Revenue Next Year | $3.58 | $6.00 |
| P/E Ratio | ★ $13.98 | $57.04 |
| Revenue Growth | ★ 7.16 | 5.74 |
| 52 Week Low | $401.90 | $10.80 |
| 52 Week High | $549.75 | $19.85 |
| Indicator | CACC | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.51 | 46.55 |
| Support Level | $469.39 | $15.18 |
| Resistance Level | $522.53 | $16.55 |
| Average True Range (ATR) | 17.38 | 0.45 |
| MACD | -0.76 | -0.07 |
| Stochastic Oscillator | 58.95 | 40.57 |
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.